Advertisement

AIDS and Behavior

, Volume 20, Issue 7, pp 1408–1422 | Cite as

Pre-exposure Prophylaxis Awareness Among Gay and Other Men who have Sex with Men in Vancouver, British Columbia, Canada

  • Nathan J. LachowskyEmail author
  • Sally Y. Lin
  • Mark W. Hull
  • Zishan Cui
  • Paul Sereda
  • Jody Jollimore
  • Ashleigh Rich
  • Julio S. G. Montaner
  • Eric A. Roth
  • Robert S. Hogg
  • David M. Moore
Original Paper

Abstract

Men who have sex with men (MSM) account for approximately half of Canada’s new HIV infections. Pre-exposure prophylaxis (PrEP), a recently established and effective HIV prevention tool for MSM is currently not approved nor publicly funded. We recruited MSM via respondent-driven sampling to complete a self-administered computer-based interview. Stratified by HIV status, multivariable logistic regression identified factors associated with PrEP awareness. Of 673 participants, 102/500 (20.9 %) HIV-negative and 63/173 (26.5 %) HIV-positive men were aware of PrEP, but none had used it. One third of PrEP-aware MSM spoke about it with friends or sex partners. Self-declared knowledge was limited. Factors associated with PrEP awareness varied by HIV status, but included greater HAART optimism for HIV-negative MSM. Among HIV-negative MSM, being PrEP unaware was associated with younger age, not always having condoms, and preferring receptive versus insertive anal sex. Future longitudinal research should identify early adopters of PrEP and its associated impacts.

Keywords

HIV/AIDS Primary prevention Pre-exposure prophylaxis Health promotion 

Resumen

Se estima que aproximadamente la mitad de los nuevos casos de infecciones por VIH en Canadá ocurre en la población de hombres que tienen sexo con hombres (HSH). Aunque la Profilaxis Pre-exposición (PrEP por sus siglas inglés, Pre-exposure prophylaxis), ha demostrado ser una estrategia efectiva para prevenir la infección por VIH, hasta el momento, no cuenta con el apoyo de fondos públicos en Canadá. En este estudio, se reclutaron HSH a través de un método que produce un muestreo dirigido por entrevistados para completar una entrevista auto-administrada por computadora. La población fue estratificada de acuerdo al estado serológico de VIH y se realizó una regresión logística multivariable para identificar factores asociados con el conocimiento de PrEP. De los 673 participantes, 102/500 (20.9 %) de los hombres VIH-negativos y 63/173 (26.5 %) de los VIH-positivos tenían conocimiento acerca del PrEP, pero ninguno lo había usado. Un tercio de los individuos que tenían conocimiento del PrEP, lo habían conversado con amigos o parejas sexuales. Conocimiento reportado por los propios participantes fue mínimo. Los factores asociados con conocimiento del PrEP variaron según el estado serológico de VIH, pero incluyeron mayor optimismo relacionado al HAART entre los HSH VIH-negativos. En este mismo grupo, no tener conocimiento del PrEP fue asociado con una edad mas joven, no siempre tener condones y preferencia por sexo anal receptivo versus insertivo. Los resultados obtenidos en este estudio resaltan la necesidad de que futuros estudios longitudinales identifiquen adoptadores tempranos del PrEP y sus impactos asociados.

Palabras clave

VIH/SIDA Prevención primaria Profilaxis Pre-exposición Promoción de salud 

Notes

Acknowledgments

The authors would like to thank the Momentum Health Study participants, office staff and community advisory board, as well as our community partner agencies, Health Initiative for Men, YouthCo HIV and Hep C Society, and Positive Living Society of BC. Momentum is funded through the National Institute on Drug Abuse (R01DA031055-01A1) and the Canadian Institutes for Health Research (MOP-107544). NJL is supported by a CANFAR/CTN Postdoctoral Fellowship Award. JSGM is supported with grants paid to his institution by the British Columbia Ministry of Health and by the US National Institutes of Health (R01DA036307). JSGM has also received limited unrestricted funding, paid to his institution, from Abbvie, Bristol-Myers Squibb, Gilead Sciences, Janssen, Merck, and ViiV Healthcare. DMM is supported by a Scholar Award from the Michael Smith Foundation for Health Research (#5209).

References

  1. 1.
    Public Health Agency of Canada (PHAC). Population-specific HIV/AIDS Status Report: gay, bisexual, two-spirit and other men who have sex with men. Centre for Communicable Diseases and Infection Control. PHAC. 2013.Google Scholar
  2. 2.
    Public Health Agency of Canada (PHAC). HIV and AIDS in Canada: Surveillance Report to December 31, 2013. Minister of Public Works and Government Services Canada. 2014.Google Scholar
  3. 3.
    Kurth AE, Celum C, Baeten JM, Vermund SH, Wasserheit JN. Combination HIV prevention: significance, challenges, and opportunities. Curr HIV/AIDS Rep. 2011;8(1):62–72.CrossRefPubMedPubMedCentralGoogle Scholar
  4. 4.
    Grant R, Lama J, Anderson P, et al. Preexposure Chemoprophylaxis for HIV Prevention in Men Who Have Sex with Men. N Engl J Med. 2010;30(363):2587–99.CrossRefGoogle Scholar
  5. 5.
    Baeten JM, Donnell DD, Ndase P, et al. Antiretroviral prophylaxis for HIV prevention in heterosexual men and women. N Engl J Med. 2012;367(5):399–410.CrossRefPubMedPubMedCentralGoogle Scholar
  6. 6.
    Thigpen M, Kebaabetswe P, Paxton L, et al. Antiretroviral preexposure prophylaxis for heterosexual HIV transmission in Botswana. N Engl J Med. 2012;2(367):423–34.CrossRefGoogle Scholar
  7. 7.
    Van Damme L, Corneli A, Ahmed K, et al. Preexposure prophylaxis for HIV infection among African women. N Engl J Med. 2012;367(5):411–22.CrossRefPubMedPubMedCentralGoogle Scholar
  8. 8.
    Marrazzo J, Ramjee G, Richardson B, et al. Tenofovir-based preexposure prophylaxis for HIV infection among African women. N Engl J Med. 2015;11(372):509–18.CrossRefGoogle Scholar
  9. 9.
    Choopanya K, Martin M, Suntharasamai P, et al. Antiretroviral prophylaxis for HIV infection in injecting drug users in Bangkok, Thailand (the Bangkok Tenofovir Study): a randomised, double-blind, placebo-controlled phase 3 trial. Lancet. 2013;381(9883):2083–90.CrossRefPubMedGoogle Scholar
  10. 10.
    McCormack S & Dunn D. Pragmatic open-label randomised trial of preexposure prophylaxis: the PROUD study. In: Conference on retroviruses and opportunistic infections. 2015Google Scholar
  11. 11.
    Molina JM, Capitatn C, Spire B, et al. On demand PrEP with oral TDF-FTC in MSM: Results of the ANRS Ipergay trial. In: Conference on retroviruses and opportunistic infections. 2015.Google Scholar
  12. 12.
    Gilead Sciences. Pre-Exposure Prophyaxis (PrEP) for HIV Prevention. www.gilead.com/~/media/files/pdfs/other/preexposure%20prophylaxis%2082515.pdf?la=en Accessed 7 Jan 2016.
  13. 13.
    Kellerman SE, Hutchinson AB, Begley EB, Boyett BC, Clark HA, Sullivan P. Knowledge and use of HIV pre-exposure prophylaxis among attendees of minority gay pride events, 2004. J Acquir Immune Defic Syndr. 2006;43(3):376–7.CrossRefPubMedGoogle Scholar
  14. 14.
    Al-Tayyib AA, Thrun MW, Haukoos JS, Walls NE. Knowledge of pre-exposure prophylaxis (PrEP) for HIV prevention among men who have sex with men in Denver Colorado. AIDS Behav. 2014;18(S3):340–7.CrossRefPubMedPubMedCentralGoogle Scholar
  15. 15.
    Galindo G, Walker J, Hazelton P, et al. Community member perspectives from transgender women and men who have sex with men on pre-exposure prophylaxis as an HIV prevention strategy: implications for implementation. Implement Sci. 2012;7(1):116.CrossRefPubMedPubMedCentralGoogle Scholar
  16. 16.
    Golub S, Kowalczyk W, Weinberger C, Parsons J. Preexposure prophylaxis and predicted condom use among high-risk men who have sex with men. J Acquir Immune Defic Syndr. 2010;54(5):548–55.CrossRefPubMedPubMedCentralGoogle Scholar
  17. 17.
    Krakower DS, Mimiaga MJ, Rosenberger JG, et al. Limited awareness and low immediate uptake of pre-exposure prophylaxis among men who have sex with men using an internet social networking site. PLoS ONE. 2012;7(3):e33119.CrossRefPubMedPubMedCentralGoogle Scholar
  18. 18.
    Liu A, Kittredge P, Vittinghoff E, et al. Limited knowledge and use of hiv post- and pre-exposure prophylaxis among gay and bisexual men. J Acquir Immune Defic Syndr. 2008;47(2):241–7.CrossRefPubMedGoogle Scholar
  19. 19.
    Mimiaga M, Case P, Johnson C, Safren S, Mayer K. Preexposure antiretroviral prophylaxis attitudes in high-risk boston area men who report having sex with men: limited knowledge and experience but potential for increased utilization after education. J Acquir Immune Defic Syndr. 2009;50(1):77–83.CrossRefPubMedPubMedCentralGoogle Scholar
  20. 20.
    Nodin N, Carballo-Diéguez A, Ventuneac AM, Balan IC, Remien R. Knowledge and acceptability of alternative HIV prevention bio-medical products among MSM who bareback. AIDS Care. 2008;20(1):106–15.CrossRefPubMedGoogle Scholar
  21. 21.
    Rucinski K, Mensah N, Sepkowitz K, Cutler B, Sweeney M, Myers J. Knowledge and use of pre-exposure prophylaxis among an online sample of young men who have sex with men in New York city. AIDS Behav. 2013;17(6):2180–4.CrossRefPubMedGoogle Scholar
  22. 22.
    Mayer KH, Oldenburg CE, Novak DS, Elsesser SA, Krakower DS, Mimiaga MJ. Early Adopters: Correlates of HIV Chemoprophylaxis Use in Recent Online Samples of US Men Who Have Sex with Men. AIDS Behav. 2015. doi: 10.1007/s10461-015-1237-1.Google Scholar
  23. 23.
    Lourenço L, Lima VD, Heath K, et al. Process monitoring of an HIV treatment as prevention program in British Columbia, Canada. J Acquir Immune Defic Syndr. 2014;67(3):e94–109.CrossRefPubMedPubMedCentralGoogle Scholar
  24. 24.
    Johnston KM, Levy AR, Lima VD, et al. Expanding access to HAART: a cost-effective approach for treating and preventing HIV. AIDS. 2010;24(12):1929–35.CrossRefPubMedGoogle Scholar
  25. 25.
    Forrest JI, Stevenson B, Rich A, et al. Community mapping and respondent-driven sampling of gay and bisexual men’s communities in Vancouver, Canada. Cult Health Sex. 2014;16(3):288–301.CrossRefGoogle Scholar
  26. 26.
    Van de Ven P, Crawford J, Kippax S, Knox S, Prestage G. A scale of optimism-scepticism in the context of HIV treatments. AIDS Care. 2000;12(2):171–6.CrossRefPubMedGoogle Scholar
  27. 27.
    Nimmons D, Folkman S. Other-sensitive motivations for safer sex among gay men: expanding paradigms for HIV prevention. AIDS Behav. 1999;3:313–24.CrossRefGoogle Scholar
  28. 28.
    Kalichman S, Rompa D. Sexual sensation seeking and sexual compulsivity scales: reliability, validity and predicting HIV risk behavior. J Pers Assess. 1995;65(3):586–601.CrossRefPubMedGoogle Scholar
  29. 29.
    Volz E, Wejnert C, Cameron C, Spiller M, Barash V, Degani I, Heckathorn DD. Respondent-Driven Sampling Analysis Tool (RDSAT) Version 7.1. Ithaca: Cornell University; 2012.Google Scholar
  30. 30.
    Heckathorn DD. A new approach to the study of hidden populations social problems. Soc Probl. 1977;4(2):174–99.Google Scholar
  31. 31.
    Volz E, Heckathorn DD. Probability based estimation theory for respondent driven sampling. J Off Stat. 2008;24(1):79–97.Google Scholar
  32. 32.
    Lima VD, Geller J, Bangsberg DR, et al. The effect of adherence on the association between depressive symptoms and mortality among HIV-infected individuals first initiating HAART. AIDS. 2007;9:1175–83.CrossRefGoogle Scholar
  33. 33.
    Brown JL, Sales JM, DiClemente RJ. Combination HIV prevention interventions: the potential of integrated behavioral and biomedical approaches. Curr HIV/AIDS Rep. 2014;11(4):363–75.CrossRefPubMedPubMedCentralGoogle Scholar
  34. 34.
    Snowden JM, Wei C, McFarland W. Prevalence, correlates and trends in seroadaptive behaviours among men who have sex with men from serial cross-sectional surveillance in San Francisco, 2004–2011. Sex Transm Infect. 2014;90(6):498–504.CrossRefPubMedGoogle Scholar
  35. 35.
    Jollimore J for Health Initiative for Men. Gilead: Please ask Health Canada to approve Truvada for PrEP. Health Initiative for Men. http://www.petitions24.com/gilead_please_make_health_canada_application_for_truvada_as_prep. Accessed 7 Jan 2016.
  36. 36.
    Leonardi M, Lee E, Tan DH. Awareness of, usage of and willingness to use HIV pre-exposure prophylaxis among men in downtown Toronto, Canada. Int J STD AIDS. 2011;22(12):738–41.CrossRefPubMedGoogle Scholar
  37. 37.
    Rosser B, Wilkerson JM, Smolenski DJ, Oakes JM. The future of Internet-based HIV prevention: a report on key findings from the Men’s INTernet (MINTS-I, II) Sex Studies. AIDS Behav. 2011;15(S1):S91–100.CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2016

Authors and Affiliations

  • Nathan J. Lachowsky
    • 1
    • 2
    Email author
  • Sally Y. Lin
    • 1
  • Mark W. Hull
    • 1
  • Zishan Cui
    • 1
  • Paul Sereda
    • 1
  • Jody Jollimore
    • 3
  • Ashleigh Rich
    • 1
  • Julio S. G. Montaner
    • 1
    • 2
  • Eric A. Roth
    • 4
    • 5
  • Robert S. Hogg
    • 1
    • 6
  • David M. Moore
    • 1
    • 2
  1. 1.British Columbia Centre for Excellence in HIV/AIDSVancouverCanada
  2. 2.Faculty of MedicineUniversity of British ColumbiaVancouverCanada
  3. 3.Health Initiative for MenVancouverCanada
  4. 4.University of VictoriaVictoriaCanada
  5. 5.Centre for Addictions Research of British ColumbiaVictoriaCanada
  6. 6.Faculty of Health SciencesSimon Fraser UniversityBurnabyCanada

Personalised recommendations